Symbotic Inc vs 10X Genomics Inc — how do they compare? Symbotic Inc trades at $43.33 (market cap $5.19B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Symbotic Inc and 10X Genomics Inc are close in size by market cap, and 10X Genomics Inc is trading nearer its 52-week high, Symbotic Inc nearer its low. Which is the better fit depends on your goals.
| SYM | TXG | |
|---|---|---|
Market Cap | $5.19B | $5.48B |
Sector | Technology | Health |
52-Week High | $87.30 | $45.80 |
52-Week Low | $38.57 | $11.34 |
Enterprise Value | $3.18B | $5.02B |
Trailing returns across standard periods
Latest headlines on both assets
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →